Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling.

MLA

Sheng, Weiwei, et al. “Musashi2 Promotes EGF-Induced EMT in Pancreatic Cancer via ZEB1-ERK/MAPK Signaling.” Journal of Experimental & Clinical Cancer Research (17569966), vol. 39, no. 1, Jan. 2020, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s13046-020-1521-4.

APA

Sheng, W., Shi, X., Lin, Y., Tang, J., Jia, C., Cao, R., Sun, J., Wang, G., Zhou, L., & Dong, M. (2020). Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. Journal of Experimental & Clinical Cancer Research (17569966), 39(1), 1–14. https://doi.org/10.1186/s13046-020-1521-4

Chicago

Sheng, Weiwei, Xiaoyang Shi, Yiheng Lin, Jingtong Tang, Chao Jia, Rongxian Cao, Jian Sun, Guosen Wang, Lei Zhou, and Ming Dong. 2020. “Musashi2 Promotes EGF-Induced EMT in Pancreatic Cancer via ZEB1-ERK/MAPK Signaling.” Journal of Experimental & Clinical Cancer Research (17569966) 39 (1): 1–14. doi:10.1186/s13046-020-1521-4.